1-Aminomethyl-5-methoxyindane1-Aminomethyl-5-methoxyindane (AMMI), is a drug developed by a team led by David E. Nichols at Purdue University, which acts as a selective serotonin releasing agent (SSRA) and binds to the serotonin transporter (SERT) with similar affinity relative to DFMDA (Ki = 2,000nM). Read from the Drugbox of the Wikipedia article 1-Aminomethyl-5-methoxyindane, revision 1365165622.

Property

Value

Formula

C11H15NO, 177.25 g/mol

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.